Search for: "WATSON PHARMACEUTICALS " Results 161 - 180 of 360
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Dec 2010, 6:07 pm by Larry Jones
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
26 Feb 2014, 5:37 pm
  Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
19 Apr 2021, 9:37 am by Deb Givens
Insurance broker Aon has offered to sell assets in several EU countries and the reinsurance unit of takeover target Willis Towers Watson to gain EU antitrust approval for its $30 billion acquisition bid, a person familiar with the matter said on Monday. [read post]
27 Jul 2010, 7:18 pm
Magistrate Judge on July 13 ruled that the president and CEO of Watson Pharmaceuticals made a “colorable claim that the FTC may have exceeded its authority by using its investigative power to pressure Watson to enter into a business deal that the FTC considers desirable. [read post]
12 Oct 2010, 8:56 pm by Kelly
(FDA Law Blog) Lyrica (Pregabalin) – US: Pfizer files patent infringement suit against Lupin in response to Para IV certification filing (Patent Docs) Opana (Oxymorphone) – US: Watson reaches settlement with Endo over Opana ER (SmartBrief) OsmoPrep (Sodium biphosphate, Sodium phosphate) – US: Salix Pharma and Novel Labs settle OsmoPrep patent litigation (Patent Docs) Sanctura XR (Trospium) – US: Allergan file patent infringement complaints against Paddock… [read post]
24 Mar 2013, 9:56 pm by Lisa Larrimore Ouellette
Watson), in which the Court will decide when a brand-name pharmaceutical company may offer a "reverse payment" settlement to a generic company in exchange for the generic dropping a patent challenge and staying out of the market. [read post]
18 Jun 2013, 10:24 am by Michael Carrier
Hatch-Waxman at the Supreme Court: Supporting Cert. in CiproOne of the most debated issues in patent and antitrust law today involves pharmaceutical patent settlements. [read post]
1 Dec 2011, 2:02 pm by Tom Lamb
Coincidence, But Ironic, Given Several Recent Medical Studies Which Suggest Drospirenone (DRSP) Causes Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) On November 29, 2011 Watson Pharmaceuticals issued this press release, "Watson's Generic Yaz(R) Receives FDA Approval", which begins as follows: Watson Pharmaceuticals, Inc. [read post]
4 Mar 2010, 12:09 pm by Neal Fortin
Please RSVP with Faye Watson (cotton@msu.edu or call 517-353-3174).To learn more about the seminar topic, see Mr. [read post]
15 Mar 2011, 6:29 am by Larry Ribstein
Watson is an early sighting of a highly disruptive force. [read post]
4 Dec 2018, 2:00 am by James Davis, Editor, HR Daily Advisor
Europe continues to have lower trend due to the influence of the integrated government health systems and their ability to negotiate lower pharmaceutical costs. [read post]
21 Mar 2018, 3:28 am by Jane Meacham, Contributing Editor
Some pharmaceutical companies also still sponsor traditional pensions for most salaried new hires. [read post]
21 Mar 2018, 3:28 am by Jane Meacham, Contributing Editor
Some pharmaceutical companies also still sponsor traditional pensions for most salaried new hires. [read post]
13 Mar 2013, 1:55 pm by Brett Frischmann
Watson Pharmaceuticals, Inc., a case concerning reverse payment settlements of patent litigation. [read post]
25 Jun 2012, 2:01 pm by Brenda Fulmer
The Judicial Panel will also consider requests to establish several new MDLs and transfer cases: MDL No. 2372 - Fentanyl Patch cases against Watson - Request has been made to transfer 11 cases pending in federal courts in Arizona, Florida, Kentucky, Maryland, and Missouri to the federal court in Chicago. [read post]